Johnson & Johnson (JNJ) Payout Ratio (2009 - 2026)
Johnson & Johnson's (JNJ) quarterly Payout Ratio came in at 0.58 in Q2 2026, up 3.19% year-over-year from 0.57 in Q2 2025, and down 2.5% quarter-over-quarter from 0.6 in Q1 2026.
Analysis
Johnson & Johnson (JNJ) Payout Ratio (2009 - 2026) Analysis & Trends
Johnson & Johnson has disclosed Payout Ratio across 18 years of filings, most recently posting 0.58 for Q2 2026.
- In Q2 2026, Payout Ratio rose 3.19% year-over-year to 0.58; the TTM figure through Jun 2026 stood at 0.6 (up 12.48% YoY), while the FY2025 annual figure was 0.46, down 45.05% from the prior year.
- Payout Ratio came in at 0.58 for Q2 2026 at Johnson & Johnson, down from 0.6 in the prior quarter.
- In the past five years, Payout Ratio ranged from a high of 1.17 in Q1 2023 to a low of 43.26 in Q2 2023.
- Average Payout Ratio over 5 years is 2.09, with a median of 0.6 recorded in 2025.
- Year-over-year, Payout Ratio slumped 7967.44% in 2023 and soared 904.51% in 2024.
- Over 5 years, Payout Ratio stood at 0.55 in 2022, then rose by 28.67% to 0.71 in 2023, then advanced by 22.91% to 0.87 in 2024, then declined by 29.63% to 0.61 in 2025, then slipped by 4.72% to 0.58 in 2026.
- Per Business Quant data, the three most recent Payout Ratio figures were 0.58 in Q2 2026, 0.6 in Q1 2026, and 0.61 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 648.10 Bn | 627.34 Bn | 17.26 Bn |
| 2 | AbbVie | 441.84 Bn | 435.27 Bn | 12.70 Bn |
| 3 | Merck | 364.97 Bn | 357.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 267.08 Bn | 259.39 Bn | 11.24 Bn |
| 5 | Pfizer | 158.83 Bn | 147.13 Bn | 10.94 Bn |
| 6 | Sanofi | 52.56 Bn | 45.18 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.29 Bn | 44.29 Bn | - |
| 8 | Incyte | 25.35 Bn | 20.81 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.31 Bn | 18.65 Bn | 683.80 Mn |
| 10 | Neurocrine Biosciences | 15.54 Bn | 15.15 Bn | 935.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 0.58 |
| Mar 29, 2026 | 0.60 |
| Dec 28, 2025 | 0.61 |
| Sep 28, 2025 | 0.61 |
| Jun 29, 2025 | 0.57 |
| Mar 30, 2025 | 0.27 |
| Dec 29, 2024 | 0.87 |
| Sep 29, 2024 | 1.11 |
| Jun 30, 2024 | 0.64 |
| Mar 31, 2024 | 0.88 |
| Dec 31, 2023 | 0.71 |
| Oct 1, 2023 | 0.11 |
| Jul 2, 2023 | 0.60 |
| Apr 2, 2023 | -43.26 |
| Jan 1, 2023 | 1.17 |
| Apr 3, 2022 | 0.55 |
| Oct 3, 2021 | 0.76 |
| Jul 4, 2021 | 0.44 |
| Apr 4, 2021 | 0.43 |
| Jan 3, 2021 | 1.53 |